Comparison of clonidine and melatonin for treating insomnia in children 6 to12 years old with anxiety disorders

Comparison of clonidine and melatonin for treating insomnia in children 6 to12 years old with anxiety disorder

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20220820055756N1

Enrollment

Registered

2022-10-16

Start date

2022-09-22

Completion date

Unknown

Last updated

2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sleep disorder. Sleep disorders not due to a substance or known physiological condition

Interventions

Intervention 1: Intervention group:24 children between 6 to 12 years old with sleep disorders due to anxiety disorders who will be treated with melatonin (3 mg). For first three day melatonin will be

Eligibility

Sex/Gender

All

Age

6 Years to 12 Years

Inclusion criteria

Inclusion criteria: parent consent for participating in study 6 to12 years old children suffering from atleast one of the anxiety disorders sleep disorder due to anxiety disorders

Exclusion criteria

Exclusion criteria: parents dissatisfaction with participating suffering from physical disease using other sedative and hypnotic drugs except clonidine and melatonin history of allergy to clonidine and melatonin

Design outcomes

Primary

Measure	Time frame
Quality of sleep. Timepoint: week4 and 6. Method of measurement: children's sleep questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Helen Behmanesh

Hamedan University of Medical Sciences

behmanesh.helen@yahoo.com009838274191

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Mar 7, 2026